IL2 and cancer: A range of cancer immunotherapy approaches has been tested in pediatric cancer patients, including the use of cytokines like IL-2 [157], adoptive therapies like CAR-T and NK cell therapies [158,159], the use of targeted mAbs [160], immune checkpoint inhibitors [161], or oncolytic viruses that selectively infect and destroy cancer cells [162].